Arthneeti

BDH Industries Share Price & Earnings Call Analysis

₹412.00+1.25% today
Market cap
₹237 Cr
P/E
20.27
ROE
14.83%
PEG
2.09
Price to sales
2.37
Debt to equity
0.03
52W high / low
₹590 / ₹351
Sales growth (5Y)
10.80%
EBITDA margin
15.27%
Net profit margin
11.27%
Promoter holding
49.70%
Sales (last year)
₹100 Cr

Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does BDH Industries Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Pharmaceuticals & Biotechnology companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹480 Cr19.1
240%+Up 0–2%₹212 Cr16.1
340%+Flat₹17,925 Cr—
440%+Flat₹5,223 Cr39.1
540%+Flat₹4,268 Cr—
640%+Flat₹40 Cr—

Sign up free to see every company in the sector ranking and track BDH Industries Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Pharmaceuticals & Biotechnology ranking

Financials of BDH Industries Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of BDH Industries Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +22.7218.3119.3521.0627.1116.2616.2316.2017.8218.6218.9629.3429.03
Expenses +20.2016.3516.1817.5723.3014.3013.1812.6714.7516.5015.6325.1124.82
Operating Profit2.521.963.173.493.811.963.053.533.072.123.334.234.21
OPM %11.09%10.70%16.38%16.57%14.05%12.05%18.79%21.79%17.23%11.39%17.56%14.42%14.50%
Other Income +0.340.370.410.370.430.380.430.460.570.550.550.530.61
Interest0.070.040.030.020.100.020.040.010.010.010.030.010.01
Depreciation0.130.130.130.130.180.220.230.230.230.220.220.220.22
Profit before tax2.662.163.423.713.962.103.213.753.402.443.634.534.59
Tax %28.20%25.00%26.61%25.07%25.25%25.24%25.23%25.07%26.76%25.00%27.82%22.96%37.25%
Net Profit +1.911.622.512.782.961.572.412.812.491.832.623.492.88
EPS in Rs3.322.814.364.835.142.734.194.884.323.184.556.065.00

Financials of BDH Industries Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +444643415259576974866796
Expenses +404238364551496064735582
Operating Profit4455799911121214
OPM %9%9%11%13%14%15%15%13%15%14%17%14%
Other Income +121111111222
Interest000011000000
Depreciation111111111111
Profit before tax45557891011131215
Tax %32%33%33%27%26%27%27%24%26%25%26%29%
Net Profit +33345667810911
EPS in Rs4.465.615.806.538.3910.3211.0512.5414.2417.1416.1018.78
Dividend Payout %39%37%36%36%34%25%28%29%28%26%28%27%

Financials of BDH Industries Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital666666666666
Reserves182123252832374349566371
Borrowings +9988139925912
Other Liabilities +191517181818191820231720
Total Liabilities525254576665716980938799
Fixed Assets +131323232221202019202019
CWIP040000000000
Investments000000000000
Other Assets +383531344444514961736780
Total Assets525254576665716980938799

Financials of BDH Industries Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +647-0-411136-215-2
Cash from Investing Activity +-0-5-5011110-022
Cash from Financing Activity +-3-1-3-33-6-2-801-10-2
Net Cash Flow3-1-1-206-0-47-16-2
Free Cash Flow6-01-1-411146-415-2
CFO/OP198%146%186%21%-24%153%35%64%82%11%153%8%

Financials of BDH Industries Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days81646763896896768212178120
Inventory Days716139958951535053306528
Days Payable20116219224418815817112313912813491
Cash Conversion Cycle-49-37-85-85-10-39-214-523958
Working Capital Days-76-72-90-60-29-316564971102116
ROCE %13%15%14%14%16%19%18%18%20%21%18%20%

Continue your research

Others in Pharmaceuticals & Biotechnology this season

  • Anthem Bioscienc (Q2 FY27)

    Q2FY27 Consolidated Revenue from Operations: ₹5,940 Mn, up 7.9% YoY from ₹5,505 Mn in Q2FY26 (Page 4). Key investor presentation takeaways from Anthem Bioscienc

  • Neuland Laboratories (Q2 FY27)

    Q2FY27 Total Income (revenue) was ₹457.2 crore, down 11.4% year-on-year (YoY) from Q2FY26. Key investor presentation takeaways from Neuland Laboratories Ltd's Q

  • Hikal (Q2 FY27)

    Consolidated Revenue Q2FY27:** ₹434 crores, up 36% YoY from ₹319 crores in Q2FY26 (Page 9) . Key investor presentation takeaways from Hikal Ltd's Q2 FY27 invest

  • Kopran (Q2 FY27)

    9,335 lakhs (~79% increase) . Key investor presentation takeaways from Kopran Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Sun Pharmaceutical Industriesvs Divis Laboratoriesvs Torrent Pharmaceuticals